ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CDMO Famar and Active Biotech Ink Clinical Manufacturing Deal contractpharma
February 05, 2021Active Biotech AB has reached a manufacturing agreement with Famar Health Care Services Madrid SAU, a European provider of pharmaceutical manufacturing and development services. -
Teva drops development of laquinimod
pharmatimes
September 14, 2018Teva Pharmaceutical Industries has decided not to pursue development of laquinimod, and has returned rights to the drug back to Swedish group Active Biotech. -
Active Biotech regains rights of laquinimod from Teva
biospectrum
September 10, 2018Laquinimod, an orally administered small molecule has primarily been developed as a potential treatment of neurodegenerative diseases such as multiple sclerosis (MS) and Huntington's disease (HD).
Pharma Sources Insight January 2025
